Ascendis Pharma A/S — SC 13G/A Filings
56 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Ascendis Pharma A/S (ASND), sorted by most recent first. Each row links to the full filing on EdgarLookup. Ascendis Pharma A/S has filed 56 SC 13G/A documents with the SEC since 2014. To view all SEC filings by Ascendis Pharma A/S, see the full filings list.
All
144
144/A
20-F
3
424B4
424B5
6-K
6-K/A
8-A12B
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-3ASR
F-3MEF
F-6
FWP
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SC 13G/A | 0001104659-24-119287 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001897612-24-001949 | Nov 14, 2024 | — |
| SC 13G/A | ASCENDIS PHARMA A/S | 0000902664-24-006521 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-255320 | Nov 12, 2024 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-24-000377 | Nov 8, 2024 | — |
| SC 13G/A | — | 0000080255-24-000814 | Feb 16, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023991 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023743 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000080255-24-000716 | Feb 14, 2024 | — |
| SC 13G/A | ASCENDIS PHARMA A/S | 0000902664-24-001603 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-030916 | Feb 12, 2024 | — |
| SC 13G/A | — | 0000315066-24-001015 | Feb 9, 2024 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-24-000008 | Feb 8, 2024 | — |
| SC 13G/A | WESTFIELD CAPITAL MANAGEMENT COMPANY, L.P. | 0001085146-24-000663 | Feb 2, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-043636 | Apr 10, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-021815 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-021469 | Feb 14, 2023 | — |
| SC 13G/A | — | 0000080255-23-002641 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-23-031590 | Feb 10, 2023 | — |
| SC 13G/A | — | 0000315066-23-001422 | Feb 9, 2023 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000846087-23-000021 | Feb 6, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-022813 | Feb 14, 2022 | — |
| SC 13G/A | ASCENDIS PHARMA A/S | 0001104659-22-022761 | Feb 14, 2022 | — |
| SC 13G/A | — | 0000080255-22-002125 | Feb 14, 2022 | — |
| SC 13G/A | — | 0000315066-22-000785 | Feb 9, 2022 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0001678858-22-000046 | Feb 4, 2022 | — |
| SC 13G/A | ASCENDIS PHARMA A/S | 0001193125-22-027586 | Feb 4, 2022 | — |
| SC 13G/A | — | 0000315066-21-001543 | May 10, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-024368 | Feb 16, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-024253 | Feb 16, 2021 | — |
| SC 13G/A | — | 0000080255-21-001238 | Feb 16, 2021 | — |
| SC 13G/A | ASCENDIS PHARMA A/S | 0001193125-21-035222 | Feb 10, 2021 | — |
| SC 13G/A | — | 0000315066-21-000824 | Feb 8, 2021 | — |
| SC 13G/A | — | 0000315066-20-001947 | Dec 10, 2020 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-103962 | Sep 10, 2020 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-20-021912 | Feb 14, 2020 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-20-021751 | Feb 14, 2020 | — |
| SC 13G/A | — | 0000080255-20-001284 | Feb 14, 2020 | — |
| SC 13G/A | — | 0000315066-20-000822 | Feb 7, 2020 | — |
| SC 13G/A | — | 0000080255-19-002847 | Jun 10, 2019 | — |
| SC 13G/A | — | 0000935836-19-000121 | Feb 14, 2019 | — |
| SC 13G/A | SC 13G/A | 0001144204-19-007216 | Feb 13, 2019 | — |
| SC 13G/A | — | 0000315066-19-000810 | Feb 13, 2019 | — |
| SC 13G/A | SC 13G/A | 0001144204-19-006286 | Feb 11, 2019 | — |
| SC 13G/A | SC 13G/A | 0001144204-19-006284 | Feb 11, 2019 | — |
| SC 13G/A | SC 13G/A | 0001144204-18-008995 | Feb 14, 2018 | — |
| SC 13G/A | — | 0000315066-18-001718 | Feb 13, 2018 | — |
| SC 13G/A | SC 13G/A | 0001144204-17-009215 | Feb 14, 2017 | — |
| SC 13G/A | AMENDMENT TO FORM SC 13G. | 0001387131-17-000875 | Feb 14, 2017 | — |
| SC 13G/A | SC 13G/A | 0001144204-17-009013 | Feb 14, 2017 | — |